ID 405187827 · FY 2019–2024 · 6 years
N-Pharma (ნ-ფარმა, n-pharma.ge) — a Tbilisi-based pharmaceutical importer and distributor (founded 2017) that sources and introduces exclusive/innovative food supplements and medicines to Georgia (e.g. Sunshine Nutrition), plus some medical devices. Import/representation, not manufacturing; active and growing through FY2024.
curated 2026-06-25
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|
| Total Revenue | 2,512 | 1,169 | 2,849 | 5,364 | 5,110 | 5,179 | +15.6% |
| Total COGS | -1,430 | -510 | -1,471 | -2,342 | -1,858 | -1,983 | +6.8% |
| Gross Profit | 1,082 | 659 | 1,378 | 3,022 | 3,252 | 3,196 | +24.2% |
| Gross Margin | 43.1% | 56.4% | 48.4% | 56.3% | 63.6% | 61.7% | |
| Total Operating Expenses | -603 | -350 | -675 | -1,093 | -1,474 | -1,951 | +26.5% |
| EBITDA | 479 | 309 | 703 | 1,929 | 1,778 | 1,245 | +21.1% |
| EBITDA Margin | 19.1% | 26.4% | 24.7% | 36.0% | 34.8% | 24.0% | |
| Total D&A | -13 | -15 | -17 | -53 | -65 | -78 | +42.3% |
| EBIT / Operating Income | 465 | 294 | 687 | 1,876 | 1,713 | 1,167 | +20.2% |
| Total Interest Expense | -46 | -24 | -8 | -31 | -50 | -86 | +13.2% |
| Profit Before Tax | 419 | 270 | 679 | 1,845 | 1,663 | 1,080 | +20.9% |
| Total Income Tax | 0 | -1 | -18 | -93 | -160 | -163 | nmf |
| Net Profit / (Loss) | 479 | 308 | 686 | 1,836 | 1,618 | 1,082 | +17.7% |
| Net Margin | 19.1% | 26.3% | 24.1% | 34.2% | 31.7% | 20.9% |
Ownership & directors from companyinfo.ge (public corporate registry).